mCPP

mCPP is widely considered unpleasant and dysphoric, inducing anxiety, headaches, and migraine attacks in susceptible individuals. It is occasionally sold as ecstasy or in party pills but lacks MDMA's euphoric effects. Individuals with personal or family histories of psychiatric disorders, panic disorder, or obsessive-compulsive disorder should avoid use as mCPP can exacerbate these conditions. CYP2D6 inhibitors including certain antidepressants and grapefruit juice significantly increase mCPP serum levels and risk of adverse effects. A reported fatality occurred in an individual with asthma who experienced a severe asthma attack after ingesting approximately 20mg of mCPP.

Also known as: Cpp, 3-cpp, Meta-chlorophenylpiperazine

Classification

Chemical: Piperazine
Psychoactive: Stimulant
Tag: Designer-drug
Tag: Phenylpiperazine
Tag: Research-Chemical
Tag: substituted piperazine
Tag: Tentative

Effects

Stimulation
Headache
Nausea
Teeth Grinding
Difficulty Urinating
Abnormal Heartbeat
Anxiety
Dysphoria
Feelings Of Impending Doom
Talkativeness
Alertness Enhancement
Mood Lift
Appetite Suppression
Decreased Libido
Visual Drifting
Tracers
Dehydration
Perception Of Bodily Heaviness

Routes of Administration

Oral

Dosage

Threshold: 15 mg
Light: 20-50 mg
Common: 50-120 mg
Strong: 120-150 mg
Heavy: 150 mg

Duration

Onset: 0.3-1 h
Comeup: 0.3-1 h
Peak: 2-4 h
Offset: 3-8 h

Harm Reduction

Check interactions before mixing substances, pay attention to dose spacing and hydration, and treat all dosage guidance as approximate rather than guaranteed safe.

Sources

Substance data is aggregated from the following public harm-reduction and reference sources.

Links

This static page is intended as a readable non-JS and prerender-friendly library export.

Get the full DrugsPRO experience

Open the interactive DrugsPRO app for search, saved items, interactions, and deeper harm reduction tools.

Get the PRO test kit. The simple, quick and reliable drug checking test kit. Visit https://protestkit.eu